Stay updated on Psilocybin for OCD Clinical Trial

Sign up to get notified when there's something new on the Psilocybin for OCD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin for OCD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes a completed Phase 1 study evaluating psilocybin for obsessive-compulsive disorder, including its treatment arms, participant criteria, and outcome measures. It also provides the study’s investigators, dates, and a related clinical-trial publication.
    Difference
    52%
    Check dated 2026-11-09T13:52:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:49:27.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:44:23.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T21:51:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T04:21:18.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, presenting an access-denied message instead of the study record content.
    Difference
    0.5%
    Check dated 2026-09-28T22:39:03.000Z thumbnail image

Stay in the know with updates to Psilocybin for OCD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin for OCD Clinical Trial page.